The Global option in the LEAD Model lets an ACO keep up to 100% of savings — and absorb up to 100% of losses. On paper, that is a board-and-finance decision.
In practice it is a clinical one, because the people whose daily choices determine whether you save or lose are the physicians — and most of them have never had capitation explained in terms that change behavior. Sign for global risk without closing that gap and you have bought a financial structure your front line cannot execute.
- Capitation inverts the incentive physicians were trained under
Fee-for-service rewards doing more. Capitation rewards doing what’s necessary. Those instincts don’t switch overnight.
Under capitation, the organization is paid prospectively to keep a population well, not per service rendered. For a physician who has spent a career in volume-based reimbursement, that is not a tweak — it is an inversion.
Until that is understood at the point of care, the contract and the behavior are misaligned — and the contract always loses that argument.
- Physicians don’t need the actuarial model — they need the translation
This is where clinical-to-strategy translation earns its keep. A physician does not need to derive the benchmark. They need to understand, concretely: an avoidable admission is no longer someone else’s cost line — it is ours. A well-managed rising-risk patient who never decompensates is a financial win, not invisible work.
The clinician’s job did not change; the scoreboard did. Someone has to make that legible in clinical language.
- Governance is where risk literacy becomes behavior
Organizations that succeed under risk do not send a memo. They build physician governance that surfaces cost and quality data clinicians trust, attributes results to decisions clinicians actually make, and lets medical leaders shape the response.
Risk that lives only in the finance department never reaches the exam room — which is the only place total cost of care is actually determined.
- The high-needs population raises the stakes
LEAD’s high-needs focus means the patients driving the most cost are also the most clinically demanding. Global risk on a complex population is unforgiving of a disengaged medical staff.
The clinical judgment about when to intervene, when to escalate, when to bring care into the home — that judgment is the financial model. You cannot outsource it to analytics.
- What to do before you sign
Three steps. Brief your physician leaders on what each risk option actually means for their work, in clinical language. Stand up the data and governance so they can see their own panel’s cost and quality. And pressure-test whether your medical staff is ready to own total cost of care, not just quality metrics.
If the honest answer is no, that is an argument for the Professional option — or for building readiness before escalating to Global.
Final Thoughts
Choosing a risk track is usually framed as a finance and strategy decision. It is also, and maybe primarily, a clinical-readiness decision.
Having spent my career between the clinic and the strategy table — trained as a physician, then in audit, now in advisory — I’ve watched capable organizations take on downside risk their physicians never understood, and then wonder why the numbers didn’t move. The contract is only as good as the front line’s grasp of it. Earn the buy-in before you sign the risk.
If you’re weighing the Global option in LEAD but haven’t translated what capitation means to your physicians, you’re taking on risk your front line can’t execute. At HealtheNomics I help organizations build the physician risk-literacy and governance that make a downside contract actually work.
Explore the services: https://healthenomics.com/services-2/
Request a strategy conversation: https://healthenomics.com/contact-us/
Connect on LinkedIn: https://www.linkedin.com/in/muhammad-ayoub-ashraf/
Website: https://www.drayoubashraf.com
Watch on YouTube: https://www.youtube.com/@HealtheNomics
